Oxadiazole derivatives active on sphingosine-1-phosphate (S1P)

Details for Australian Patent Application No. 2008339988 (hide)

Owner Glaxo Group Limited

Inventors Demont, Emmanuel Hubert; Johnson, Christopher Norbert; Skidmore, John; Wall, Ian David; Hurst, David Nigel; Heightman, Thomas Daniel; Witherington, Jason; Heer, Jag Paul

Agent Davies Collison Cave

Pub. Number AU-A-2008339988

PCT Pub. Number WO2009/080725

Priority 0821918.0 01.12.08 GB; 0725120.0 21.12.07 GB

Filing date 19 December 2008

Wipo publication date 2 July 2009

International Classifications

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07D 223/16 (2006.01) Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

C07D 267/14 (2006.01) Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms

C07D 271/06 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

15 July 2010 PCT application entered the National Phase

  PCT publication WO2009/080725 Priority application(s): WO2009/080725

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008339993-1, 2, 4 -oxadiazole compounds for the treatment of autoimmune diseases

2008339987-Oxadiazole derivatives active on sphingosine-1-phosphate (S1P)